Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Cystic Fibrosis (CF) Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Cystic Fibrosis (CF) Treatment Market

 

Global Cystic Fibrosis (CF) Treatment Market: By Product Type (Pancreatic enzyme supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration (Oral and Inhaled), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Cystic Fibrosis (CF) Treatment Market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Cystic Fibrosis (CF) Treatment Market

Cystic fibrosis is a genetic disorder that causes severe damage to secretory glands of body such as lungs, pancreas, liver and intestines. It is more common in lungs. The disease is progressive with several mutations in the genes, which causes cystic fibrosis. In cystic fibrosis, the abnormal secretions from various secretory glands builds mucus which results in improper working of the organ that is affected. The treatment of cystic fibrosis helps loosening mucus which includes physical therapy. There are various therapeutic products available for the treatment of cystic fibrosis, which include enzymes, antibiotics and others.

 

Market Dynamics: Cystic Fibrosis (CF) Treatment Market

The major factors that are driving cystic fibrosis therapeutics market includes, increasing prevalence of the cystic fibrosis, rising awareness among healthcare fraternity about cystic fibrosis therapy. Advancement in the technology, and better healthcare facilities are also some of the factors influencing the cystic fibrosis therapeutics market. However, the cystic fibrosis therapeutics market growth hindering due to high cost of the treatment, increase in complexity of disease. Moreover, patent expiries from many companies and introduction of generic drugs hold back the growth of global cystic fibrosis market

 

Market Scope: Cystic Fibrosis (CF) Treatment Market

Cystic Fibrosis (CF) treatment market is segmented based on the product type, Route of Administration.

Based on product type, the market is segmented into the following:

  • Pancreatic enzyme supplements
  • Mucolytics
  • Bronchodilators
  • CFTR Modulators

Based on the route of administration, the market is segmented into the following:

  • Oral
  • Inhalation

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Market Summary: Cystic Fibrosis (CF) Treatment Market

According to CFF’s national patient registry, the median age of the person with cystic fibrosis is currently 33.4 years. Basing on the severity of the disease, cystic fibrosis signs and symptoms vary. The Wide- research on Cystic Fibrosis (CF) resulted in dramatic improvements in the treatment of the disease, which has quadrupled the median life expectancy to 37 years of age in the U.S. In parts of the world where state-of-the-art medical care is not available, life expectancy remains much lower. In Europe, 51.8% were adults with age 18 years or more and 48.2% were less than 18 years old. New therapeutics are currently in development, of which some may provide a functional CFTR protein in patients with some versions of the gene, potentially eliminating many disease complications and allowing people with the disease to live essentially normal lives.

 

Regional Analysis:  Cystic Fibrosis (CF) Treatment Market

Geographically, global Cystic Fibrosis (CF) treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America stands for largest revenue share due to huge affected population. However, the underdiagnoses and lack of country-specific CF patient registries, Asia Pacific region would be forecasted for higher growth of the market. The region that falls next to North America is Europe. According to the European Cystic Fibrosis Society (ECFS), more than 35,500 people were suffering from cystic fibrosis in 2014. The Asian region has lesser prevalence rate. Whereas in East Asian countries like China and Japan the disease is rare. The Middle East and Africa holds the least share in the market owing to the lack of healthcare infrastructure, especially countries in the African region.

 

Competition Assessment: Cystic Fibrosis (CF) Treatment Market

Some of the players in the global Cystic Fibrosis (CF) treatment market include:

  • Vertex Pharmaceuticals Incorporated,
  • Gilead
  • AbbVie Inc
  • Novartis AG.
  • Hoffmann-La Roche Ltd
  • Alaxia, Merck & Co. Inc.
  • AIT (Advanced Inhalation Therapies)
  • ALLERGAN plc
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd.
  • Alcresta Therapeutics, Inc.
  • Chiesi FarmaceuticiSpA

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global Cystic Fibrosis (CF) Treatment Market Introduction
    • Global Cystic Fibrosis (CF) Treatment Market – Taxonomy
    • Global Cystic Fibrosis (CF) Treatment Market –Definitions
      • Product Type
      • Route of Administration
      • Distribution Channel
  1. Global Cystic Fibrosis (CF) Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cystic Fibrosis (CF) Treatment Market Dynamic Factors – Impact Analysis
    • Global Cystic Fibrosis (CF) Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Cystic Fibrosis (CF) Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Cystic Fibrosis (CF) Treatment Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Pancreatic enzyme supplements
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Mucolytics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Bronchodilators
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CFTR Modulators
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Treatment Market Forecast, By Route of Administration,2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Inhalation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Region, 2018 – 2024
  2. North America Cystic Fibrosis (CF) Treatment MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pancreatic enzyme supplements
      • Mucolytics
      • Bronchodilators
      • CFTR Modulators
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Inhalation
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • North America Cystic Fibrosis (CF) Treatment Market Dynamics – Trends
  3. Europe Cystic Fibrosis (CF) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pancreatic enzyme supplements
      • Mucolytics
      • Bronchodilators
      • CFTR Modulators
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Inhalation
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • Europe Cystic Fibrosis (CF) Treatment Market Dynamics – Trends
  4. Asia-Pacific Cystic Fibrosis (CF) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pancreatic enzyme supplements
      • Mucolytics
      • Bronchodilators
      • CFTR Modulators
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Inhalation
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • Asia-Pacific Cystic Fibrosis (CF) Treatment Market Dynamics – Trends
  5. Latin America Cystic Fibrosis (CF) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pancreatic enzyme supplements
      • Mucolytics
      • Bronchodilators
      • CFTR Modulators
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Inhalation
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • Latin America Cystic Fibrosis (CF) Treatment Market Dynamics – Trends
  6. Middle East and Africa Cystic Fibrosis (CF) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pancreatic enzyme supplements
      • Mucolytics
      • Bronchodilators
      • CFTR Modulators
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Inhalation
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cystic Fibrosis (CF) Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • MEA Cystic Fibrosis (CF) Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Vertex Pharmaceuticals Incorporated,
      • Gilead
      • AbbVie Inc
      • Novartis AG.
      • Hoffmann-La Roche Ltd
      • Alaxia, Merck & Co. Inc.
      • AIT (Advanced Inhalation Therapies)
      • ALLERGAN plc
      • AstraZeneca
      • Teva Pharmaceutical Industries Ltd.
      • Alcresta Therapeutics, Inc.
      • Chiesi FarmaceuticiSpA
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553